Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.5K Sell
11,636
-4,358
-27% -$13.6K ﹤0.01% 714
2026
Q1
$46.7K Sell
15,994
-8,718
-35% -$24.9K ﹤0.01% 723
2025
Q4
$61K Sell
24,712
-2,007
-8% -$4.78K ﹤0.01% 764
2025
Q3
$59.6K Sell
26,719
-3,718
-12% -$8.51K ﹤0.01% 757
2025
Q2
$73.4K Buy
30,437
+3,725
+14% +$9.07K ﹤0.01% 762
2025
Q1
$62.2K Buy
26,712
+2,592
+11% +$5.18K ﹤0.01% 783
2024
Q4
$44.6K Hold
24,120
﹤0.01% 787
2024
Q3
$58.9K Hold
24,120
﹤0.01% 783
2024
Q2
$49.4K Hold
24,120
﹤0.01% 761
2024
Q1
$59.8K Hold
24,120
﹤0.01% 759
2023
Q4
$67.5K Hold
24,120
﹤0.01% 741
2023
Q3
$62.2K Sell
24,120
-270
-1% -$781 ﹤0.01% 730
2023
Q2
$77.6K Buy
24,390
+790
+3% +$2.32K ﹤0.01% 720
2023
Q1
$66.6K Sell
23,600
-487
-2% -$1.27K ﹤0.01% 667
2022
Q4
$65.5K Buy
+24,087
New +$70.2K 0.01% 627

Other funds holding ABEV

Metis Global Partners's ABEV Position: Q2 2026 in Review

Metis Global Partners reduced its Ambev (ABEV) stake by 27% in Q2 2026, selling an estimated $13.6K and leaving 11,636 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Metis Global Partners first reported a position in ABEV in Q4 2022 and has held it in 15 quarters since. The position peaked at $77.6K in Q2 2023. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Metis Global Partners held 11,636 shares of Ambev worth $36.5K as of Q2 2026.
  • Metis Global Partners sold 4,358 Ambev shares in Q2 2026, an estimated $13.6K.
  • Ambev made up ﹤0.01% of Metis Global Partners's portfolio in Q2 2026, its #714 holding.
  • Metis Global Partners first reported a position in Ambev in Q4 2022 and has held it in 15 quarters since.
  • Metis Global Partners's Ambev position peaked at $77.6K in Q2 2023.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.